TOBACCO-FREE KIDS ACTION FUND

Lobbying Report: July 1st -September 30th, 2025 (Action Fund)  Federal (under tobacco issue code)   Legislation:   Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 2064, Helping Tobacco Users Quit Act H.R. 1, One Big Beautiful Bill Act H. R. 901 (118th Congress), Disposable ENDS Product Enforcement Act of 2023 H.R. 2111, To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 H.R. 4404, the Hookah Clarification Act H.R. 9425 (118th Congress), the Tobacco User Fee Modernization Act of 2024 S. 819/H.R. 1798, End Tobacco Loopholes Act S. 2171/H.R.3855, a bill to prohibit smoking on premises of Veterans Health Administration facilities Issues: CDC FY 25 state National Tobacco Control Program grants CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping Congressional efforts to reduce e-cigarette and tobacco use FDA authority over tobacco products FDA authorization of tobacco products FDA destruction authority FDA enforcement against unauthorized e-cigarettes FDA multiagency task force to combat the distribution and sale of illegal e-cigarettes FDA tobacco user fees FDA track and trace system for tobacco products GAO report on federal efforts to address unauthorized e-cigarettes HHS reorganization FDAs proposed rule to prohibit menthol cigarettes FDA Proposed rule to set a maximum nicotine level for cigarettes Tobacco cessation in general U.S. Preventive Services Task Force Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  

GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues:  Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Agencies Visited:  Centers for Disease Control and Prevention US House of Representatives  US Senate